PapersFlow Research Brief
Medical Imaging and Pathology Studies
Research Guide
What is Medical Imaging and Pathology Studies?
Medical Imaging and Pathology Studies is the interdisciplinary research area that develops and applies radiologic imaging and anatomic pathology (including histology) methods, standards, and evidence to detect, classify, and manage disease.
The field spans imaging terminology and reporting standards, disease classification systems, and diagnostic/management guidelines that connect image findings to pathologic entities, as illustrated by "Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) and "The 2015 World Health Organization Classification of Lung Tumors" (2015).
Research Sub-Topics
CT Imaging of Pulmonary Nodules
This sub-topic covers protocols for detecting, characterizing, and managing incidental pulmonary nodules on computed tomography scans using Fleischner Society guidelines. Researchers study nodule growth rates, malignancy risk models, and follow-up imaging strategies.
Cardiac Transthyretin Amyloidosis Imaging
This sub-topic focuses on non-invasive diagnosis using technetium pyrophosphate scintigraphy, cardiac MRI, and echocardiography for ATTR amyloid cardiomyopathy. Researchers develop diagnostic algorithms combining imaging with biomarkers.
Idiopathic Pulmonary Fibrosis Radiology
This sub-topic examines high-resolution CT patterns like usual interstitial pneumonia for IPF diagnosis and progression monitoring. Researchers correlate imaging phenotypes with genetic and clinical outcomes.
WHO Lung Tumor Classification Imaging
This sub-topic addresses radiological-pathological correlations for the 2015 WHO classification of lung adenocarcinoma subtypes and neuroendocrine tumors. Researchers study imaging biomarkers for genomic profiling.
Renal Osteodystrophy Imaging
This sub-topic covers radiographic, DXA, and QCT assessment of bone turnover, mineralization, and volume in CKD-MBD per KDIGO guidelines. Researchers evaluate imaging for fracture risk and treatment monitoring.
Why It Matters
Standardized definitions, classifications, and management pathways in medical imaging and pathology studies directly affect clinical decisions in high-burden diseases, particularly in thoracic medicine and oncology. "Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" (2017) operationalized CT-detected nodule follow-up into a consensus pathway, enabling consistent management of a common real-world imaging finding. "The 2015 World Health Organization Classification of Lung Tumors" (2015) provided a shared tumor taxonomy used to align radiology, histopathology, and clinical communication for lung cancer diagnosis and reporting. In cardiology, "Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis" (2016) addressed delayed/missed diagnosis by supporting diagnostic workflows that can avoid routine histologic confirmation in appropriate contexts, while "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy" (2018) linked accurate disease identification to a therapy that reduced all-cause mortality and cardiovascular-related hospitalizations versus placebo. Collectively, these works show how imaging-pathology alignment moves beyond description toward actionable diagnosis, risk stratification, and treatment selection.
Reading Guide
Where to Start
Start with "Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) because it establishes the shared language needed to read, compare, and reproduce thoracic imaging–pathology studies.
Key Papers Explained
Terminology and measurement come first: "Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) standardizes descriptors used in thoracic CT interpretation. Those descriptors feed into action: "Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" (2017) turns a common CT finding into a structured management pathway, often determining when pathology is obtained. Classification anchors correlation studies: "The 2015 World Health Organization Classification of Lung Tumors" (2015) provides the disease taxonomy that imaging studies commonly aim to predict or discriminate. Disease-specific reviews frame evidence integration: "Idiopathic pulmonary fibrosis" (2011), "Idiopathic pulmonary fibrosis" (2017), and "Idiopathic Pulmonary Fibrosis" (2018) contextualize how imaging patterns and, when required, pathology contribute to diagnosis and management. In a parallel imaging–pathology workflow, "Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis" (2016) formalizes when imaging-led diagnosis can substitute for histology, and "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy" (2018) shows why accurate identification matters by linking diagnosis to reduced all-cause mortality and cardiovascular-related hospitalizations versus placebo.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Within the provided corpus, the most immediate frontier is tightening the linkage between standardized thoracic imaging language ("Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008)), guideline-driven decision points ("Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" (2017)), and tumor ground truth definitions ("The 2015 World Health Organization Classification of Lung Tumors" (2015)) so that imaging models and prospective studies can be compared across sites. Another active direction is formal evaluation of when noninvasive diagnostic pathways can safely replace biopsy, building from the rationale and structure in "Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis" (2016) and linking those pathways to treatment decisions supported by "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy" (2018). A third direction is improving early recognition and diagnostic confidence in fibrotic lung disease while minimizing misclassification, consistent with the clinical emphasis in "Idiopathic Pulmonary Fibrosis" (2018) and the broader syntheses in "Idiopathic pulmonary fibrosis" (2011) and "Idiopathic pulmonary fibrosis" (2017).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The 2015 World Health Organization Classification of Lung Tumors | 2015 | Journal of Thoracic On... | 4.4K | ✕ |
| 2 | Fleischner Society: Glossary of Terms for Thoracic Imaging | 2008 | Radiology | 4.2K | ✕ |
| 3 | Tafamidis Treatment for Patients with Transthyretin Amyloid Ca... | 2018 | New England Journal of... | 2.5K | ✓ |
| 4 | Guidelines for Management of Incidental Pulmonary Nodules Dete... | 2017 | Radiology | 2.3K | ✕ |
| 5 | Idiopathic pulmonary fibrosis | 2011 | The Lancet | 2.1K | ✕ |
| 6 | Diagnosis of Bone and Joint Disorders | 1987 | — | 2.0K | ✕ |
| 7 | Definition, evaluation, and classification of renal osteodystr... | 2006 | Kidney International | 1.9K | ✕ |
| 8 | Idiopathic pulmonary fibrosis | 2017 | The Lancet | 1.9K | ✕ |
| 9 | Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis | 2016 | Circulation | 1.9K | ✓ |
| 10 | Idiopathic Pulmonary Fibrosis | 2018 | New England Journal of... | 1.9K | ✕ |
In the News
ICR-led project awarded major funding to improve safety ...
The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research.
CWRU spinout company receives $2.5M federal grant for ...
CLEVELAND, Ohio — The National Institutes of Health awarded a $2.5 million research grant to support medical technology invented at Case Western Reserve University, the university said in a recent ...
UC Davis Health receives $2.8 million grant from NIH to ...
Health] (NIH) to study the mechanisms of cell therapy using an AI-based digital pathology tool.
PathOrchestra: a comprehensive foundation model for computational pathology with over 100 diverse clinical-grade tasks
The complexity and variability of high-resolution pathological images present significant challenges in computational pathology. While AI-driven pathology foundation models have advanced the field,...
FDA Grants Three Breakthrough Designations to Harrison.ai
Oct. 9, 2025 — Harrison.ai has received three FDA Breakthrough Device Designations for CT imaging solutions, further solidifying its position at the forefront of next-generation AI for driving effi...
Code & Tools
MONAI is a PyTorch -based, open-source framework for deep learning in healthcare imaging, part of the PyTorch Ecosystem . Its ambitions are as foll...
TIAToolbox is a computational pathology toolbox developed by the TIA Centre. It provides an end-to-end API for pathology image analysis using best ...
The aim of this project is to provide a tool for WSI processing in a reproducible environment to support clinical and scientific research. histolab...
Open-source python package for the extraction of Radiomics features from 2D and 3D images and binary masks. Support: https://discourse.slicer.org/c...
The main goal of FAST is to make it easier to do high-performance processing, neural network inference, and visualization of medical images utilizi...
Recent Preprints
PathOrchestra: a comprehensive foundation model for computational pathology with over 100 diverse clinical-grade tasks
Pathology is heralded as the gold standard for disease diagnosis, encompassing a broad range of tasks including tumor detection 1 , 2 , typing 3 , 4 , grading 5 , 6 , molecular expression analysis ...
Foundation Models in Medical Imaging - A Review and ...
Despite their potential, the application of FMs in medical image analysis is still emerging. This review focuses on vision-based FMs for medical imaging across three primary domains: pathology, rad...
A multimodal vision–language model for generalizable annotation-free pathology localization
Existing deep learning models for defining pathology from clinical imaging data rely on expert annotations and lack generalization capabilities in open clinical environments. Here we present a gene...
Multimodal deep learning framework integrating multiphase CT and histopathological whole slide imaging for predicting recurrence in ccRCC
### Similar content being viewed by others ### Integration of multi-scale radiomics and deep learning for Ki-67 prediction in clear cell renal carcinoma ArticleOpen access06 December 2025 ### M...
Multimodal analysis of whole slide images in colorectal cancer
Multimodal models have enabled the integration of digital pathology, radiology, clinical information, and omics data to enhance Colorectal cancer (CRC) care. This systematic review critically appra...
Latest Developments
Recent developments in Medical Imaging and Pathology Studies research include advancements in AI-assisted imaging, such as deep learning-based image classification integrating pathology and radiology (Scientific Reports, July 2025), AI applications in tumor diagnosis and treatment (PMC, August 2025), digital transformation and molecular insights in pathology with AI and big data analytics (ScienceDirect, February 2026), and innovative imaging technologies like virtual staining and foundation models for precision oncology (CAP, February 2026; Nature, January 2025).
Sources
Frequently Asked Questions
What is the role of standardized terminology in thoracic imaging research and practice?
"Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) compiled a glossary intended to replace earlier thoracic radiography and CT glossaries, reflecting the need to update terms as imaging practice changed. A shared vocabulary reduces ambiguity when correlating CT patterns with pathologic diagnoses and when comparing results across studies.
How do pulmonary nodule management guidelines connect imaging findings to downstream diagnostic workup?
"Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" (2017) revised earlier Fleischner guidance to reflect newer information and current thinking on nodule management. The guideline format translates an imaging observation (incidental nodule on CT) into follow-up actions that often determine whether and when pathology sampling is pursued.
Which reference is most used for lung tumor classification in imaging–pathology correlation studies?
"The 2015 World Health Organization Classification of Lung Tumors" (2015) is a highly cited reference that provides a standardized classification framework for lung tumors. Using a common classification supports consistent mapping between imaging phenotypes, histologic subtypes, and clinical reporting.
How can cardiac transthyretin amyloidosis be diagnosed without routine biopsy, and why does that matter for imaging-pathology studies?
"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis" (2016) described a diagnostic approach motivated by the limited specificity of echocardiography and the traditional requirement for histologic confirmation. The work is central to imaging-pathology studies because it formalizes when imaging-led pathways can substitute for tissue diagnosis in a specific disease context.
Which study links accurate diagnosis of transthyretin amyloid cardiomyopathy to a concrete treatment benefit?
"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy" (2018) reported that tafamidis was associated with reductions in all-cause mortality and cardiovascular-related hospitalizations compared with placebo. This connects imaging- and pathology-supported case identification to a therapy with measurable clinical outcome differences.
Which papers summarize idiopathic pulmonary fibrosis (IPF) in ways that are relevant to imaging and pathology interpretation?
"Idiopathic pulmonary fibrosis" (2011), "Idiopathic pulmonary fibrosis" (2017), and "Idiopathic Pulmonary Fibrosis" (2018) are major syntheses of IPF that support how clinicians interpret and act on diagnostic evidence. "Idiopathic Pulmonary Fibrosis" (2018) explicitly emphasizes early recognition and intervention, aligning with the use of imaging patterns and, when needed, pathology to establish diagnosis and guide care.
Open Research Questions
- ? How can thoracic imaging descriptors from "Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) be operationalized into reproducible, multi-center imaging–pathology correlation protocols for lung disease subtyping?
- ? Which CT-derived nodule risk features most strongly predict specific tumor entities as defined in "The 2015 World Health Organization Classification of Lung Tumors" (2015), and how should this influence updates to "Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" (2017)?
- ? In suspected transthyretin amyloid cardiomyopathy, what are the failure modes and boundary conditions of the nonbiopsy pathway described in "Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis" (2016), and when should pathology confirmation still be required?
- ? For idiopathic pulmonary fibrosis, how should imaging and pathology evidence be combined to enable earlier recognition without increasing misclassification, consistent with the emphasis on early recognition in "Idiopathic Pulmonary Fibrosis" (2018)?
- ? How should musculoskeletal imaging criteria from "Diagnosis of Bone and Joint Disorders" (1987) be reconciled with systemic bone-mineral disorder definitions in "Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)" (2006) for studies where imaging and pathology are both used as reference standards?
Recent Trends
The provided topic-level data indicates a large literature base (98,463 works), with 5-year growth listed as N/A. Within the most-cited works, recent consolidation is visible in updated thoracic standards and guidance ("Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017" ) and in major disease syntheses that emphasize earlier recognition and intervention ("Idiopathic Pulmonary Fibrosis" (2018)).
2017High citation counts for shared standards and classifications—such as "The 2015 World Health Organization Classification of Lung Tumors" with 4,385 citations and "Fleischner Society: Glossary of Terms for Thoracic Imaging" (2008) with 4,186 citations—reflect continuing reliance on consensus definitions to make imaging–pathology studies comparable and clinically interpretable.
2015Research Medical Imaging and Pathology Studies with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Medical Imaging and Pathology Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.